| Business

Larger text Larger text Smaller text Smaller text | Order Photo Reprints

AstraZeneca to cut 1,600 in U.S., U.K.

Email Newsletters

Click here to sign up for one of our email newsletters.

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

AZN $46.18 -$0.28

at close on MONDAY

By The Associated Press
Tuesday, March 19, 2013, 12:01 a.m.

Struggling Anglo-Swedish drugmaker AstraZeneca PLC said Monday that it will eliminate 1,600 jobs, mostly in the United States and United Kingdom, as its new CEO starts a major research and development reorganization.

The cuts come just weeks after the company reported big drops in revenue and net income for 2012 and forecast continuing difficulties as generic competition hurts sales.

The job reductions amount to nearly 3 percent of AstraZeneca's 57,200 workers.

worldwide and are part of moves affecting several major AstraZeneca sites in the UK, US and Sweden.

Even the global headquarters will be shifted, from London to Cambridge, England, as the company moves many of its scientists near top centers for bioscience research. Rivals have been doing the same, to be near those talent pools and to increase collaborations with scientists at universities and small biotech companies.

Subscribe today! Click here for our subscription offers.



Show commenting policy

Most-Read Business Headlines

  1. AB InBev ups its offer for SABMiller to create beer giant
  2. Finding balance key to PNC Capital Markets chief’s success
  3. 2,000 more layoffs at U.S. Steel debated
  4. ATI expects quarterly loss of $142M
  5. UAW threatens strike at Fiat Chrysler
  6. Eat’n Park sells Cura division that serves hospitals and senior living
  7. Energy efficiency goes mainstream with help of regulations, demand
  8. Alcoa lands $1B airplane fastener contract from Airbus
  9. Coal’s upside? Things can’t get much worse after a dire 2015
  10. IMF predicts global economic growth will shrink
  11. Rally in energy shares fails to lift market as biotech freefall continues